However, a consensus interpretation of the p. V37I variant of GJB2 was launched by the ClinGen Hearing Loss Expert Panel in 2019; they reviewed case–control studies and functional, computational, allelic, and segregation data regarding the variant. The gene discussed is GJB2; the disease is hearing loss disorder.